| 替罗非班在老年冠心病PCI治疗中的应用 |
| |
| 引用本文： | 怯红晓,董平栓.替罗非班在老年冠心病PCI治疗中的应用[J].医学综述,2008,14(20):3160-3162. |
| |
| 作者姓名： | 怯红晓 董平栓 |
| |
| 作者单位： | 河南科技大学第一附属医院心内科,河南,洛阳,471003 |
| |
| 摘 要： | 近年来,人们越来越认识到抗血小板治疗是急性冠状动脉综合征(ACS)治疗的重要组成部分,替罗非班是一种非肽类GPⅡb/Ⅲa受体拮抗剂,它通过阻断血小板聚集的最后共同通路而有效抑制血小板聚集和血栓形成。本文综述替罗非班在老年ACS经皮冠状动脉介入治疗中的应用现状。
|
| 关 键 词： | 替罗非班 急性冠状动脉综合征 经皮冠状动脉介入术 老年 |
Tirofiban in Elderly Patients with Acute Coronary Syndrome Undergoing Percutan-eous Coronary Intervention |
| |
| KAI Hong-xiao,DONG Ping-shuan.Tirofiban in Elderly Patients with Acute Coronary Syndrome Undergoing Percutan-eous Coronary Intervention[J].Medical Recapitulate,2008,14(20):3160-3162. |
| |
| Authors: | KAI Hong-xiao DONG Ping-shuan |
| |
| Institution: | KAI Hong-xiao,DONG Ping-shuan.(Department of Cardiology,the First Affiliated Hospital of Henan Science , Technology University,Luoyang 471003,China) |
| |
| Abstract: | In recent years, anti-platelet therapy has been regarding as an important part in treatment of acute coronary syndrome （ACS）. As a non-peptide GPⅡb/Ⅲa receptor antagonist, tirofiban can inhibit platelet aggregation by blocking the final common-Road and effectively inhibiting platelet aggregation and thrombosis. This article reviewed the present situation of tirofiban in percutaneous coronary intervention in elderly patients with acute coronary. |
| |
| Keywords: | Tirofiban Acute coronary syndrome Percutaneous coronary intervention Aged |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
